Articles

Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine

Center for Cancer and Blood Disorders, Department of Pediatrics, University of Colorado, Aurora
Division of Hematology, Department of Medicine, University of Colorado, Aurora
Division of Hematology, Department of Medicine, University of Colorado, Aurora
Division of Hematology, Department of Medicine, University of Colorado, Aurora
Department of Biostatistics and Informatics, University of Colorado, Aurora
Department of Biostatistics and Informatics, University of Colorado, Aurora
Molecular Diagnostics, Children’s Hospital Colorado, Aurora
Molecular Diagnostics, Children’s Hospital Colorado, Aurora
Pediatric Pathology, Children’s of Alabama, Birmingham
Department of Pathology, University of Colorado, Aurora
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York
Division of Hematology, Department of Medicine, University of Colorado, Aurora
Division of Hematology, Department of Medicine, University of Colorado, Aurora
Division of Hematology, Department of Medicine, University of Colorado, Aurora
Vol. 109 No. 6 (2024): June, 2024 https://doi.org/10.3324/haematol.2023.283790